TABLE II.
Mean (95% CI) |
P Value (ANOVA)* |
||||
Vehicle Group | iPTH Group | Treatment | Duration | Treatment*Duration | |
Osseointegration (%) | |||||
Metaphysis | 0.019 | N.S. | N.S. | ||
Wk 2 | 45.6 (38.3, 52.9) | 53.6 (46.5, 60.8) | |||
Wk 4 | 41.0 (16.8, 65.1) | 57.3 (52.1, 62.5) | |||
Epiphysis | N.S. | N.S. | N.S. | ||
Wk 2 | 17.4 (2.15, 32.7) | 15.6 (0.381, 30.9) | |||
Wk 4 | 16.5 (5.16, 27.7) | 22.8 (12.0, 33.6) | |||
Bone area fraction (%) | |||||
Metaphysis | <0.001 | N.S. | N.S. | ||
Wk 2 | 32.2 (29.9, 34.5) | 47.8 (44.5, 51.2) | |||
Wk 4 | 24.1 (13.0, 35.2) | 48.4 (46.3, 50.6) | |||
Epiphysis | N.S. | N.S. | N.S. | ||
Wk 2 | 40.3 (28.6, 52.0) | 29.7 (16.5, 42.9) | |||
Wk 4 | 28.0 (17.1, 38.9) | 30.7 (19.0, 42.3) |
N.S. = not significant.